- Home
- BANC vs BHVN Comparison
BANC vs BHVN Comparison
Compare BANC & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANC
- BHVN
- Stock Information
- Founded
- BANC 1941
- BHVN 2013
- Country
- BANC United States
- BHVN United States
- Employees
- BANC N/A
- BHVN N/A
- Industry
- BANC Major Banks
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- BANC Finance
- BHVN Health Care
- Exchange
- BANC Nasdaq
- BHVN Nasdaq
- Market Cap
- BANC 2.2B
- BHVN 1.9B
- IPO Year
- BANC N/A
- BHVN 2017
- Fundamental
- Price
- BANC $13.75
- BHVN $20.24
- Analyst Decision
- BANC Buy
- BHVN Strong Buy
- Analyst Count
- BANC 12
- BHVN 14
- Target Price
- BANC $17.25
- BHVN $62.92
- AVG Volume (30 Days)
- BANC 2.7M
- BHVN 2.2M
- Earning Date
- BANC 04-23-2025
- BHVN 05-16-2025
- Dividend Yield
- BANC 2.91%
- BHVN N/A
- EPS Growth
- BANC N/A
- BHVN N/A
- EPS
- BANC 0.65
- BHVN N/A
- Revenue
- BANC $964,190,000.00
- BHVN N/A
- Revenue This Year
- BANC $12.25
- BHVN N/A
- Revenue Next Year
- BANC $9.00
- BHVN $65.26
- P/E Ratio
- BANC $21.08
- BHVN N/A
- Revenue Growth
- BANC 415.34
- BHVN N/A
- 52 Week Low
- BANC $11.52
- BHVN $15.79
- 52 Week High
- BANC $18.08
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- BANC 53.65
- BHVN 43.79
- Support Level
- BANC $12.98
- BHVN $18.75
- Resistance Level
- BANC $13.98
- BHVN $24.06
- Average True Range (ATR)
- BANC 0.41
- BHVN 2.00
- MACD
- BANC 0.10
- BHVN 0.21
- Stochastic Oscillator
- BANC 56.20
- BHVN 42.39
About BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.